Analgesics (Pharmacies) - Slovakia

  • Slovakia
  • Revenue in the Analgesics market is projected to reach US$64.37m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.90%, resulting in a market volume of US$81.78m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$11.29 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Slovakia has been experiencing steady growth in recent years.

Customer preferences:
Slovakian consumers have shown a strong preference for analgesics purchased from pharmacies rather than other retail channels. This is likely due to the perception that pharmacies offer a higher level of expertise and trustworthiness in providing healthcare products. Additionally, customers in Slovakia tend to value convenience and prefer to have easy access to analgesics when needed.

Trends in the market:
One notable trend in the Analgesics (Pharmacies) market in Slovakia is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors. Firstly, OTC analgesics are more easily accessible and do not require a prescription, which is appealing to consumers who want quick relief from pain without the hassle of visiting a doctor. Secondly, the rising healthcare costs in Slovakia have led consumers to seek more affordable alternatives, and OTC analgesics offer a cost-effective solution. Another trend in the market is the growing popularity of natural and herbal analgesics. Slovakian consumers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This has led to an increased demand for analgesics made from natural ingredients, such as herbal extracts and essential oils.

Local special circumstances:
Slovakia has a well-established healthcare system with a strong emphasis on pharmaceutical care. Pharmacies in the country are regulated and supervised by the Slovak Chamber of Pharmacists, ensuring that they meet certain standards of quality and professionalism. This has contributed to the trust that consumers have in pharmacies as a reliable source of healthcare products, including analgesics. Furthermore, the aging population in Slovakia has also had an impact on the Analgesics (Pharmacies) market. As the population ages, the incidence of chronic pain conditions, such as arthritis, increases. This has created a higher demand for analgesics, both prescription and OTC, to manage pain and improve quality of life for the elderly population.

Underlying macroeconomic factors:
The growing economy in Slovakia has played a significant role in the development of the Analgesics (Pharmacies) market. As disposable incomes have increased, consumers have more purchasing power and are able to afford healthcare products, including analgesics. The stable economic environment and low unemployment rate have also contributed to consumer confidence and willingness to spend on healthcare. Additionally, the government in Slovakia has implemented policies to improve healthcare access and affordability, which has further fueled the demand for analgesics. The introduction of the electronic prescription system has made it easier for patients to obtain prescriptions for analgesics, and the reimbursement system has made these medications more affordable for those who need them. In conclusion, the Analgesics (Pharmacies) market in Slovakia is developing due to customer preferences for pharmacy channels, the increasing demand for OTC analgesics, the popularity of natural and herbal products, the trust in the healthcare system, the aging population, the growing economy, and government policies to improve healthcare access and affordability. These factors have created a favorable market environment for analgesics in Slovakia.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)